Beck Bode, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Beck Bode, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$680.49 - $826.97 $136,778 - $166,220	-201 Reduced 11.75%	1,510 $1.24 Million
Q4 2022 Feb 07, 2023	BUY	$705.89 - $766.39 $903,539 - $980,979	1,280 Added 296.98%	1,711 $1.23 Million
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $2,295 - $2,897	4 Added 0.94%	431 $297,000
Q2 2022 Jul 29, 2022	SELL	$548.35 - $738.84 $14,805 - $19,948	-27 Reduced 5.95%	427 $252,000
Q1 2022 May 02, 2022	BUY	$595.12 - $698.43 $270,184 - $317,087	454 New	454 $317,000
Q4 2021 Feb 07, 2022	SELL	$543.48 - $670.97 $6.89 Million - $8.51 Million	-12,681 Closed	0 $0
Q3 2021 Oct 22, 2021	SELL	$574.03 - $680.96 $109,639 - $130,063	-191 Reduced 1.48%	12,681 $7.67 Million
Q2 2021 Jul 29, 2021	BUY	$472.8 - $558.54 $23,640 - $27,927	50 Added 0.39%	12,872 $7.19 Million
Q1 2021 May 10, 2021	BUY	$446.73 - $548.2 $5.71 Million - $7.01 Million	12,785 Added 34554.05%	12,822 $6.07 Million
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $20,155 - $24,353	37 New	37 $21,000
Q2 2020 Aug 13, 2020	SELL	$493.32 - $643.92 $3.03 Million - $3.95 Million	-6,132 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $2.06 Million - $3.03 Million	6,132 New	6,132 $3.23 Million

1,532

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $78.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Beck Bode, LLC, based on Form 13F filings with the SEC.

Stay updated on Beck Bode, LLC with notifications on news.